首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
简体中文
A multipronged Tα1 reset of CD8+ T cell cytotoxicity against breast cancer | Synapse
March 3, 2026
A multipronged Tα1 reset of CD8+ T cell cytotoxicity against breast cancer
SM
Smriti Mishra
Thermax (India)
GT
Gaurang Telang
US Biologic (United States)
AS
Anurag Sureshbabu
Bharath University
See all
Key Points
Increased cytotoxicity was observed in CD8+ T cells, indicating enhanced immune response.
Specific treatment with Tα1 improved effectiveness against breast cancer in lab models.
Study included a combination of treatments to assess their impact on immune pathways and cancer.
Findings suggest potential new therapeutic strategies for treating breast cancer using Tα1.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Mishra et al. (Fri,) studied this question.
synapsesocial.com/papers/69a75f3ac6e9836116a2a776
https://doi.org/https://doi.org/10.1016/j.humimm.2026.111678